Member Exclusive

Regulating advanced therapies in the UK: an interview with Michael Rawlins

In this interview with Professor Sir Michael Rawlins, chairman, Medicines and Healthcare products Regulatory Agency, learn more about the future of regenerative medicine in the UK.

Go to the profile of RegMedNet
Sep 09, 2017

Please sign in or register for FREE

No comments yet.